Detalles de la búsqueda
1.
Genomic diagnostics within a medically underserved population: efficacy and implications.
Genet Med
; 20(1): 31-41, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28726809
2.
Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
Arthritis Rheum
; 64(3): 876-84, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22223180
3.
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
Nat Med
; 29(10): 2615-2624, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37770652
4.
Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee.
Pain
; 155(7): 1245-1252, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24686255
5.
Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity.
Curr Med Res Opin
; 24(9): 2531-43, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18667113
6.
Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.
Arthritis Rheum
; 58(8): 2443-52, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18668535
7.
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.
Arthritis Rheum
; 58(8): 2432-42, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18668591
Resultados
1 -
7
de 7
1
Próxima >
>>